namcp Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Providers plan to pursue Medicare's chronic care management program

Kryptiq conducted a benchmark survey to gauge providers' pursuit of the newly available payments in light of the Centers for Medicare and Medicaid Services starting to reimburse providers last Jan. 1. Caregivers who actively manage...

source: By Scott E. Rupp
Search past issues
Search products and services

Point-of-care technology is the key to providing patient care and efficient workflows. PC Connection, Inc. has the experts and services to ensure that you have the right devices and technology to provide excellent care.

source: Healthcare IT News

Robert Wachter writes: Last year, I saw an ad recruiting physicians to a Phoenix-area hospital. It promoted state-of-the-art operating rooms, dazzling radiology equipment and a lovely suburban location. But only one line was printed in bold: “No EMR” In today’s...

source: The New York Times

Human embryonic stem cell therapy was recently shown to reverse Type 1 diabetes in mice, and now new mouse studies suggest a role for stem cells in the treatment of Type 2 diabetes. Obese, diabetic mice treated with a combination of transplanted stem cell-derived pancreatic...

source: MedPage Today

Scientists at the University of Copenhagen have captured thousands of progenitor cells of the pancreas on video as they made decisions to divide and expand the organ or to specialize into the endocrine cells that regulate our blood sugar levels. The study reveals that stem...


Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Semma Therapeutics...

source: The Boston Globe

Everyone knows that different people don’t respond the same way to medications, and that “one size does not fit all.” FDA has been pushing for targeted drug therapies, sometimes called “personalized medicines” or “precision medicines,”...

source: FDA Voice


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to Genomics Biotechnology & Emerging Medical Technologies Institute e-News

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of NAMCP? Yes   No
Privacy Policy